SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-18-002850
Filing Date
2018-11-07
Accepted
2018-11-07 17:14:16
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk1822214.htm 10-Q 718399
2 EXHIBIT 3.1 exhibit_3-1.htm EX-3.1 266706
3 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 12904
4 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 12750
5 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5192
6 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5059
  Complete submission text file 0001178913-18-002850.txt   3415392

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fomx-20180930.xml EX-101.INS 585327
8 XBRL TAXONOMY EXTENSION SCHEMA fomx-20180930.xsd EX-101.SCH 30934
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fomx-20180930_cal.xml EX-101.CAL 52291
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fomx-20180930_def.xml EX-101.DEF 94757
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fomx-20180930_lab.xml EX-101.LAB 253418
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fomx-20180930_pre.xml EX-101.PRE 180480
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36621 | Film No.: 181167338
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1